ArticleslgStudy

astronomy

Trevor Lawley

Trevor Lawley is a astronomy topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Trevor Lawley rather than just read about it. In short: Trevor Lawley FMedSci is a Faculty member and Senior Group Leader in the Host-Microbiota Interactions Lab at the Wellcome Sanger Institute (WSI). He is also co-founder and Chief Scientific Officer of the biotech company Microbiotica.

Trevor Lawley — main illustration
Trevor Lawley — illustration

Key takeaways

  • Trevor Lawley belongs to astronomy; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Trevor Lawley to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Trevor Lawley from memory before moving on to harder problems.

Reference excerpt

Trevor Lawley FMedSci is a Faculty member and Senior Group Leader in the Host-Microbiota Interactions Lab at the Wellcome Sanger Institute (WSI). He is also co-founder and Chief Scientific Officer of the biotech company Microbiotica. During his career, Lawley has pioneered the application of high throughput genomic and culturing approaches to characterise enteric pathogens and investigate the microbiomes contained on and within host organisms, during periods of health and disease.

Education and career Lawley received his bachelor's degree in Biology in 1997 from Acadia University. He then studied for a PhD at the University of Alberta, in the laboratories of Diane Taylor and Laura Frost, where he studied the mechanisms that pathogenic bacteria use to disseminate antibiotic resistance genes. After his PhD, Trevor was awarded a Canadian Institutes of Health Research post-doctoral fellowship to work in the Laboratories of Stanley Falkow and Denise Monack at Stanford University, where he studied the impact of antibiotic treatment on Salmonella disease and transmission. In 2007 Lawley received a Royal Society of London Award to start a research programme on Clostridioides difficile disease and transmission at the Wellcome Sanger Institute. In 2010, he was appointed as a Career Development Fellow in the Sanger Institute Faculty and was promoted to Faculty Group Leader in 2014 and a Senior Group Leader in 2021. Lawley chairs the Wellcome Sanger Institute International Fellows programme, which focuses on empowering scientists from Low- and Middle-Income Countries through access to cutting-edge genomic technologies and training. In December 2016, Lawley, together with Gordon Dougan and Mike Romanos, co-founded the biotech company Microbiotica through £12M seed funding from Cambridge Innovation Capital, IP Group and Seventure. Microbiotica develops Live Biotherapeutic Products, biomarkers and microbiome-based technologies focused on autoimmune diseases and cancers. In 2018, Microbiotica entered into a collaboration with Genentech to discover, develop and commercialise inflammatory bowel disease (IBD)biomarkers, targets and medicines. In 2020, Microbiotica entered into a partnership with Cambridge University Hospitals and Cancer Research UK to discover and develop biomarkers and medicines for cancer immunotherapy patients with melanoma, renal cell carcinoma or lung cancer. In March 2022, Microbiotica secured Series B funding to perform two phase 1 clinical studies for treatment of patients with melanoma (MELODY-1, NCT06540391) or ulcerative colitis (COMPOSER-1, NCT06582264). The two clinical trials started in 2024.

Research Lawley leads the Host-Microbiota Interactions Lab at the Sanger Institute, which explores the relationship between humans and the bacteria and viruses that collectively form their microbiome. Lawley and his team use a range of methods and tools, including large scale metagenomic analysis, genetics, mouse and cellular models, state-of-the art microbial culturing, transcriptomics, proteomics and machine learning, to investigate the microbial communities associated with human health and a range of developmental disorders, diseases and poorly understood syndromes. They have a particular interest the roles of the microbiome in infectious disease, autoimmune disease, cancer and childhood developmental disorders. Their work has pioneered concepts, analytical tools and methodologies that, through data- and hypothesis-driven approaches, have led to foundational discoveries and enabled translation of medicines and diagnostics from the human microbiome. Lawley and his team overturned the "great plate count anomaly dogma", long held in microbial ecology, by demonstrating the majority of the human gut microbiota is culturable. This breakthrough involved bacterial culturing, biobanking and genome sequencing at scale, leading to the development of fast, affordable, yet sophisticated, high-resolution gut microbiome analysis. A major outcome of biobanking pure cultures has been experimental testing of biological hypotheses derived from metagenomic analysis, which moves the field towards studies of causation and enables the realisation of microbiome derived medicines. They focus on several key areas including:

Characterising the evolution of taxonomic and functional diversity in the human microbiome. Investigating the early-life microbiome, and how birth-mode and clinical interventions, impact microbiome acquisition and assembly. Understanding host-microbiome interactions and drivers of inflammatory disease and cancer. Studying the fundamental biology, transmission and pathogenesis of C. difficile. Lawley's group has authored over 100 papers. Their work is regularly covered in the scientific and popular press.

Awards and honours Lawley was elected as a Fellow of the Academy of Medical Sciences in 2023. In 2015 Lawley received the Peggy Lillis Foundation "Innovator Award" for Pioneering Work on Live Biotherapeutics. In 2026 Lawley was elected as Fellow of the European Academy of Microbiology.

References

Illustrations

Trevor Lawley: Image of Trevor Lawley
Image of Trevor Lawley

Worked examples

Example 1 — a first encounter with Trevor Lawley

Start with the simplest possible case. Write down what Trevor Lawley claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In astronomy, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Trevor Lawley before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Trevor Lawley ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Trevor Lawley

In research
Trevor Lawley appears in astronomy research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Trevor Lawley in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Trevor Lawley is common in secondary-school and first-year university syllabi. It links to neighbouring topics Acadia University alumni, Biotechnologists, Canadian geneticists, so understanding it makes those chapters shorter.
In everyday life
Look for Trevor Lawley outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Trevor Lawley” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Trevor Lawley in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Trevor Lawley means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Trevor Lawley out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Trevor Lawley in simple terms?

Trevor Lawley FMedSci is a Faculty member and Senior Group Leader in the Host-Microbiota Interactions Lab at the Wellcome Sanger Institute (WSI). He is also co-founder and Chief Scientific Officer of the biotech company Microbiotica.

Why does Trevor Lawley matter?

Because it connects several astronomy ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Trevor Lawley?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Trevor Lawley.

Tags

  • Acadia University alumni
  • Biotechnologists
  • Canadian geneticists
  • Canadian microbiologists
  • Fellows of the Academy of Medical Sciences (United Kingdom)
  • Living people
  • Stanford University staff
  • University of Alberta alumni
  • Wellcome Trust

Keep exploring